349 related articles for article (PubMed ID: 34569453)
1. Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations.
Martinón-Torres F; Taha MK; Knuf M; Abbing-Karahagopian V; Pellegrini M; Bekkat-Berkani R; Abitbol V
Pathog Glob Health; 2022 Mar; 116(2):85-98. PubMed ID: 34569453
[TBL] [Abstract][Full Text] [Related]
2. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
[TBL] [Abstract][Full Text] [Related]
3. Potential public health impact of a
Huang L; Snedecor SJ; Balmer P; Srivastava A
Postgrad Med; 2022 May; 134(4):341-348. PubMed ID: 33615973
[TBL] [Abstract][Full Text] [Related]
4. Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.
Bousema JC; Ruitenberg J
Int J Health Policy Manag; 2015 Sep; 4(11):757-61. PubMed ID: 26673336
[TBL] [Abstract][Full Text] [Related]
5. Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England.
Beck E; Klint J; Garcia S; Abbing V; Abitbol V; Akerborg O; Argante L; Bekkat-Berkani R; Hogea C; Neine M; Vadivelu K; Whelan J; Meszaros K
Vaccine; 2020 Nov; 38(47):7558-7568. PubMed ID: 32807531
[TBL] [Abstract][Full Text] [Related]
6. Overview of meningococcal epidemiology and national immunization programs in children and adolescents in 8 Western European countries.
Pinto Cardoso G; Lagrée-Chastan M; Caseris M; Gaudelus J; Haas H; Leroy JP; Bakhache P; Pujol JF; Werner A; Dommergues MA; Pauquet E; Pinquier D
Front Pediatr; 2022; 10():1000657. PubMed ID: 36507149
[TBL] [Abstract][Full Text] [Related]
7. Changing patterns of invasive meningococcal disease and future immunization strategies.
Taha MK; Bekkat-Berkani R; Abitbol V
Hum Vaccin Immunother; 2023 Dec; 19(1):2186111. PubMed ID: 37017273
[TBL] [Abstract][Full Text] [Related]
8. National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal disease.
Burman C; Findlow J; Marshall HS; Safadi MAP
Expert Rev Vaccines; 2023; 22(1):839-848. PubMed ID: 37767607
[TBL] [Abstract][Full Text] [Related]
9. Meningococcal Vaccination of Adolescents in the United States: Past Successes and Future Considerations.
Presa J; Findlow J; Zimet GD
J Adolesc Health; 2024 Jun; 74(6):1068-1077. PubMed ID: 38430074
[TBL] [Abstract][Full Text] [Related]
10. Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs.
Tin Tin Htar M; Jackson S; Balmer P; Serra LC; Vyse A; Slack M; Riera-Montes M; Swerdlow DL; Findlow J
BMC Public Health; 2020 Dec; 20(1):1890. PubMed ID: 33298015
[TBL] [Abstract][Full Text] [Related]
11. Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?
Tzanakaki G; Cabrnochová H; Delić S; Draganescu A; Hilfanova A; Onozó B; Pokorn M; Skoczyńska A; Tešović G
Hum Vaccin Immunother; 2024 Dec; 20(1):2301186. PubMed ID: 38173392
[TBL] [Abstract][Full Text] [Related]
12. A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine.
Ruiz Garcia Y; Abitbol V; Pellegrini M; Bekkat-Berkani R; Soumahoro L
Infect Dis Ther; 2022 Apr; 11(2):639-655. PubMed ID: 34591258
[TBL] [Abstract][Full Text] [Related]
13. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
[TBL] [Abstract][Full Text] [Related]
14. Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies.
Booy R; Gentile A; Nissen M; Whelan J; Abitbol V
Hum Vaccin Immunother; 2019; 15(2):470-480. PubMed ID: 30296197
[TBL] [Abstract][Full Text] [Related]
15. Does social deprivation correlate with meningococcal MenACWY, Hib/MenC and 4CMenB/Meningococcal Group B vaccine uptake in Northern Ireland?
Brennan OC; Moore JE; Millar BC
Ulster Med J; 2022 Jan; 91(1):9-18. PubMed ID: 35169333
[TBL] [Abstract][Full Text] [Related]
16. Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study.
Ohm M; Hahné SJM; van der Ende A; Sanders EAM; Berbers GAM; Ruijs WLM; van Sorge NM; de Melker HE; Knol MJ
Clin Infect Dis; 2022 Jul; 74(12):2173-2180. PubMed ID: 34525199
[TBL] [Abstract][Full Text] [Related]
17. Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.
Abdelnour A; Silas PE; Lamas MR; Aragón CF; Chiu NC; Chiu CH; Acuña TH; Castrejón Tde L; Izu A; Odrljin T; Smolenov I; Hohenboken M; Dull PM
Vaccine; 2014 Feb; 32(8):965-72. PubMed ID: 24397906
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis.
McMillan M; Chandrakumar A; Wang HLR; Clarke M; Sullivan TR; Andrews RM; Ramsay M; Marshall HS
Clin Infect Dis; 2021 Aug; 73(3):e609-e619. PubMed ID: 33212510
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled study.
Knuf M; Romain O; Kindler K; Walther U; Tran PM; Pankow-Culot H; Fischbach T; Kieninger-Baum D; Bianco V; Baine Y; Miller J
Eur J Pediatr; 2013 May; 172(5):601-12. PubMed ID: 23307281
[TBL] [Abstract][Full Text] [Related]
20. The impact of regional disparities on the availability of meningococcal vaccines in the US.
Schley K; Jodar E; Presa JV; Willis SJ; Prener CG
BMC Public Health; 2024 Jul; 24(1):1771. PubMed ID: 38961431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
